| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |